4-Bromo-1-methyl-1H-pyrazolo[3,4-c]pyridine, 95.0%, 100mg

6-Methyl-3,4-dihydroisoquinolin-1(2H)-one, 95.0%, 1g

3-Nitro-1H-indazole, 95.0%, 250mg

1-Pyrrolidinecarboxylic acid, 2-[(1R,2R)-3-[[(1R,2S)-2-hydroxy-1-methyl-2-phenylethyl]amino]-1-methoxy-2-methyl-3-oxopropyl]-, 1,1-dimethylethyl ester, (2S)-, 98%, 1g

5-FLUORO-2,3-DIHYDRO-1H-INDENE-1-CARBOXYLIC ACID, 95.0%, 250mg

Sodium ((2S,3R)-3-methyloxiran-2-yl)phosphonate, 95.0%, 500g

Microliter syringe MICROLITER® series 700 Point type 3, 10 µl, 701 NR, 1 piece

2,4,5-Trifluorobenzyl Bromide>98.0%(GC)(T)5g

Methyl 5-bromo-4-chloronicotinate, 95.0%, 250mg

3,4-Dihydroxy-3-cyclobutene-1,2-dione>98.0%(HPLC)(T)25g

2-{8-[(tert-butoxy)carbonyl]-8-azabicyclo[3.2.1]octan-3-yl}acetic acid, 98%, 100mg

Potassium (S)-2-(6-hydroxybenzo[d]thiazol-2-yl)-4,5-dihydrothiazole-4-carboxylate, 95.0%, 5g

4-(4-Bromophenyl)-1-methyl-1H-pyrazole, 97.0%, 5g